Detalhe da pesquisa
1.
Liposomal amphotericin B-the future.
J Antimicrob Chemother
; 77(Suppl_2): ii21-ii34, 2022 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-36426674
2.
Regional Differences in Antifungal Susceptibility of the Prevalent Dermatophyte Trichophyton rubrum.
Mycopathologia
; 186(1): 53-70, 2021 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-33313977
3.
In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
J Antimicrob Chemother
; 75(9): 2582-2586, 2020 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32516368
4.
Clinical relevance of Scedosporium spp. and Exophiala dermatitidis in patients with cystic fibrosis: A nationwide study.
Med Mycol
; 58(7): 859-866, 2020 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32030418
5.
Intraspecific Diversity and Taxonomy of Emmonsia crescens.
Mycopathologia
; 185(4): 613-627, 2020 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-32710392
6.
Facilitators of adaptation and antifungal resistance mechanisms in clinically relevant fungi.
Fungal Genet Biol
; 132: 103254, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31326470
7.
Diagnostic-driven management of invasive fungal disease in hematology in the era of prophylaxis and resistance emergence: Dutch courage?
Med Mycol
; 57(Supplement_3): S267-S273, 2019 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31292660
8.
Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Antimicrob Agents Chemother
; 62(6)2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29581111
9.
Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
J Antimicrob Chemother
; 73(5): 1389-1394, 2018 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29394399
10.
Single-Center Evaluation of an Agar-Based Screening for Azole Resistance in Aspergillus fumigatus by Using VIPcheck.
Antimicrob Agents Chemother
; 61(12)2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28923874
11.
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
J Antimicrob Chemother
; 72(9): 2548-2552, 2017 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28605488
12.
Combination of Amphotericin B and Flucytosine against Neurotropic Species of Melanized Fungi Causing Primary Cerebral Phaeohyphomycosis.
Antimicrob Agents Chemother
; 60(4): 2346-51, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26833164
13.
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.
Emerg Infect Dis
; 21(6): 1041-4, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25988348
14.
In vitro antifungal susceptibility of Trichophyton violaceum isolated from tinea capitis patients.
J Antimicrob Chemother
; 70(4): 1072-5, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25492394
15.
Emergence of fusarioses in a university hospital in Turkey during a 20-year period.
Eur J Clin Microbiol Infect Dis
; 34(8): 1683-91, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25994844
16.
Susceptibility breakpoints for amphotericin B and Aspergillus species in an in vitro pharmacokinetic-pharmacodynamic model simulating free-drug concentrations in human serum.
Antimicrob Agents Chemother
; 58(4): 2356-62, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24514094
17.
Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.
Antimicrob Agents Chemother
; 58(6): 3285-92, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24687495
18.
Pharmacokinetics of caspofungin in ICU patients.
J Antimicrob Chemother
; 69(12): 3294-9, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25139840
19.
Absence of COVID-19 associated mucormycosis in a tertiary intensive care unit in the Netherlands.
Sci Rep
; 13(1): 22134, 2023 12 13.
Artigo
Inglês
| MEDLINE | ID: mdl-38092785
20.
Epidemiological cutoff values for azoles and Aspergillus fumigatus based on a novel mathematical approach incorporating cyp51A sequence analysis.
Antimicrob Agents Chemother
; 56(5): 2524-9, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22330922